gdc

Ovarian Cancer

Listen to the Voices of Cancer Survivors
Ovarian CancerSurvivorship
Annette McElhiney, PhD, notes the psychosocial needs of patients with cancer, survivors, and caregivers. As an ovarian cancer survivor, she describes the help provided by the recently launched “Steps Through Ovarian Cancer” program.
Lynparza Extends Survival by More Than 1 Year in Women with Relapsed Ovarian Cancer and BRCA Mutation, Should Become Standard Maintenance Therapy
Ovarian Cancer
The follow-up results of more than 5 years of the multicenter phase 3 SOLO2 clinical trial of women with ovarian cancer were presented at the 2020 ASCO annual meeting, showing improved survival with the use of Lynparza (olaparib) compared with placebo.
Zejula Now Approved as First-Line Maintenance Therapy in All Patients with Ovarian Cancer
FDA Approvals, News & UpdatesOvarian Cancer
In April 2020, the FDA approved Zejula for long-term maintenance therapy for all patients with advanced ovarian cancer, regardless of any gene mutations.
Life After a Cancer Diagnosis
Patient StoriesOvarian Cancer
Julie Silver ran into many “bumps in the road” after she was diagnosed with stage IV ovarian cancer. Despite many difficulties along the way, today her life is filled with gratitude and appreciation.
Drugs for Ovarian Cancer
Ovarian Cancer
Here are the drugs and financial support services available to patients receiving treatment for Ovarian Cancer.
Zejula Approved for HRD-Positive Advanced Ovarian Cancer
Ovarian Cancer
Late last year, the PARP inhibitor Zejula was approved by the FDA for patients with HRD mutation associated with advanced ovarian, fallopian tube, or primary peritoneal cancer, offering a new treatment option for women with these types of cancer.
Ovarian Cancer Patient Advocacy Organizations
Ovarian Cancer
There are a number of excellent organizations providing resources and support to you as a patient with ovarian cancer or a caregiver.
Ovarian Cancer: Progress Occurs, but Far Too Slowly
Ovarian Cancer
As a retired college professor, Dr. McElhiney uses her personal experience with ovarian cancer to advocate for other patients, urging faster development of new treatment options.
What on Earth Is a “Biomarker”?
Ovarian CancerBiomarkersCancer ScreeningIssue Introductions
In her Introduction to the special edition of CONQUER titled Understanding Biomarkers & Molecular Testing, Lillie D. Shockney, RN, BS, MAS, ONN-CG, briefly explains what biomarkers are, why they are important, and what you should know about them.  
Page 1 of 2
Results 1 - 10 of 19

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country